June 28, 2016
The Japanese Society for Helicobacter Research (JSHR) recommends the proton pump inhibitor (PPI) esomeprazole (brand name: Nexium) and the potassium-competitive acid blocker (P-CAB) vonoprazan (Takecab) as standard treatments for the first and second eradication of Helicobacter pylori in its new...read more